| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Semaphorin | 5.99e-04 | 20 | 34 | 2 | IPR027231 | |
| Domain | SEMA | 1.45e-03 | 31 | 34 | 2 | PS51004 | |
| Domain | Sema | 1.45e-03 | 31 | 34 | 2 | SM00630 | |
| Domain | Semap_dom | 1.45e-03 | 31 | 34 | 2 | IPR001627 | |
| Domain | Sema | 1.45e-03 | 31 | 34 | 2 | PF01403 | |
| Domain | Plexin_repeat | 1.54e-03 | 32 | 34 | 2 | IPR002165 | |
| Domain | PSI | 1.54e-03 | 32 | 34 | 2 | PF01437 | |
| Domain | Myb_DNA-binding | 1.84e-03 | 35 | 34 | 2 | PF00249 | |
| Domain | PSI | 2.90e-03 | 44 | 34 | 2 | IPR016201 | |
| Domain | PSI | 3.17e-03 | 46 | 34 | 2 | SM00423 | |
| Domain | SANT | 3.73e-03 | 50 | 34 | 2 | SM00717 | |
| Domain | SANT/Myb | 4.03e-03 | 52 | 34 | 2 | IPR001005 | |
| Domain | C1_1 | 4.82e-03 | 57 | 34 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 6.04e-03 | 64 | 34 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 6.04e-03 | 64 | 34 | 2 | PS50081 | |
| Domain | C1 | 6.23e-03 | 65 | 34 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 6.41e-03 | 66 | 34 | 2 | IPR002219 | |
| Domain | DEAD | 7.80e-03 | 73 | 34 | 2 | PF00270 | |
| Domain | DEAD/DEAH_box_helicase_dom | 7.80e-03 | 73 | 34 | 2 | IPR011545 | |
| Domain | - | 1.07e-02 | 746 | 34 | 5 | 3.40.50.300 | |
| Pubmed | Misexpression of the constitutive Rpgr(ex1-19) variant leads to severe photoreceptor degeneration. | 9.28e-07 | 2 | 34 | 2 | 21546531 | |
| Pubmed | Shear stress-regulated miR-27b controls pericyte recruitment by repressing SEMA6A and SEMA6D. | 2.78e-06 | 3 | 34 | 2 | 28453731 | |
| Pubmed | 2.84e-06 | 1285 | 34 | 9 | 35914814 | ||
| Pubmed | Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders. | 9.26e-06 | 5 | 34 | 2 | 33004838 | |
| Pubmed | 1.83e-05 | 52 | 34 | 3 | 26633812 | ||
| Pubmed | 4.84e-05 | 686 | 34 | 6 | 29987050 | ||
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 6.08e-05 | 12 | 34 | 2 | 24179230 | |
| Pubmed | 1.10e-04 | 16 | 34 | 2 | 29859889 | ||
| Pubmed | 1.10e-04 | 16 | 34 | 2 | 22632726 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.22e-04 | 262 | 34 | 4 | 36880596 | |
| Pubmed | 2.11e-04 | 118 | 34 | 3 | 30979931 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.52e-04 | 588 | 34 | 5 | 38580884 | |
| Pubmed | ICK is essential for cell type-specific ciliogenesis and the regulation of ciliary transport. | 2.53e-04 | 24 | 34 | 2 | 24797473 | |
| Pubmed | 2.74e-04 | 25 | 34 | 2 | 12522145 | ||
| Pubmed | 2.74e-04 | 25 | 34 | 2 | 26494787 | ||
| Pubmed | 3.45e-04 | 28 | 34 | 2 | 18617019 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 5.06e-04 | 1489 | 34 | 7 | 28611215 | |
| Pubmed | 5.41e-04 | 35 | 34 | 2 | 28172500 | ||
| Pubmed | 6.04e-04 | 169 | 34 | 3 | 31462741 | ||
| Pubmed | 6.38e-04 | 38 | 34 | 2 | 28680062 | ||
| Pubmed | 7.36e-04 | 421 | 34 | 4 | 36976175 | ||
| Pubmed | Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. | 7.43e-04 | 41 | 34 | 2 | 15561718 | |
| Pubmed | 9.75e-04 | 47 | 34 | 2 | 35462405 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q22 | 4.33e-03 | 132 | 34 | 2 | chr15q22 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 2.90e-04 | 20 | 23 | 2 | 736 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.05e-03 | 53 | 23 | 2 | 532 | |
| Coexpression | GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN | 5.72e-06 | 200 | 34 | 5 | M6966 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.75e-06 | 172 | 34 | 4 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 8.95e-06 | 173 | 34 | 4 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.15e-06 | 174 | 34 | 4 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.15e-06 | 174 | 34 | 4 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 190 | 34 | 4 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 190 | 34 | 4 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 190 | 34 | 4 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.40e-05 | 194 | 34 | 4 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 1.40e-05 | 194 | 34 | 4 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 153 | 34 | 3 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | Ciliated_cells-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.18e-04 | 154 | 34 | 3 | 3b938e23324f7edb56797b4a76fb96ff588142cf | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 155 | 34 | 3 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.35e-04 | 158 | 34 | 3 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-04 | 163 | 34 | 3 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-04 | 166 | 34 | 3 | a41a20cef053c67da2d435e3e132ce28f1661c03 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-04 | 167 | 34 | 3 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-04 | 167 | 34 | 3 | 91b14df450bfb6a2b406c88f8c75cd51eeb9e82b | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 167 | 34 | 3 | 69caf4a53805f8c104d7dd8f88665fc992e23720 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.81e-04 | 168 | 34 | 3 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-04 | 168 | 34 | 3 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.86e-04 | 169 | 34 | 3 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-04 | 169 | 34 | 3 | a1efc20e34a81ae32f8d278a5486811ade03ef24 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 2.91e-04 | 170 | 34 | 3 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.96e-04 | 171 | 34 | 3 | 6e7ade1d14a3ec4c566476aac3eb509bd2661e39 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.96e-04 | 171 | 34 | 3 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.01e-04 | 172 | 34 | 3 | ba36581ae339191a12a6d3ead39eaf69d78be10e | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 172 | 34 | 3 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-04 | 173 | 34 | 3 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 34 | 3 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.11e-04 | 174 | 34 | 3 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-04 | 174 | 34 | 3 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-04 | 174 | 34 | 3 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-04 | 174 | 34 | 3 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-04 | 174 | 34 | 3 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 175 | 34 | 3 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-04 | 175 | 34 | 3 | 8958c5c30437d20a4abd70d7527990f7e2a68b93 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.17e-04 | 175 | 34 | 3 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.22e-04 | 176 | 34 | 3 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.22e-04 | 176 | 34 | 3 | 75412d58438d71c49a6096bb2ef12b7f349653d8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 176 | 34 | 3 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 3.27e-04 | 177 | 34 | 3 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 177 | 34 | 3 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-04 | 177 | 34 | 3 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 177 | 34 | 3 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.33e-04 | 178 | 34 | 3 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-04 | 178 | 34 | 3 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.33e-04 | 178 | 34 | 3 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.38e-04 | 179 | 34 | 3 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.38e-04 | 179 | 34 | 3 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-04 | 179 | 34 | 3 | d0fa700648db8ce76a8aa689879a25048299fa40 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.38e-04 | 179 | 34 | 3 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-04 | 179 | 34 | 3 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-04 | 179 | 34 | 3 | 2e49b215b71438400aebb483f2c2c08d5e956961 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.44e-04 | 180 | 34 | 3 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.44e-04 | 180 | 34 | 3 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.44e-04 | 180 | 34 | 3 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-04 | 180 | 34 | 3 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.44e-04 | 180 | 34 | 3 | 1c1b25f1d22518db5469707131510daae84716a3 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.50e-04 | 181 | 34 | 3 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.50e-04 | 181 | 34 | 3 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 3.50e-04 | 181 | 34 | 3 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-04 | 181 | 34 | 3 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.50e-04 | 181 | 34 | 3 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.50e-04 | 181 | 34 | 3 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-04 | 181 | 34 | 3 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 3.50e-04 | 181 | 34 | 3 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.55e-04 | 182 | 34 | 3 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 3.55e-04 | 182 | 34 | 3 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.55e-04 | 182 | 34 | 3 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 3.55e-04 | 182 | 34 | 3 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 3.55e-04 | 182 | 34 | 3 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-04 | 183 | 34 | 3 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-04 | 183 | 34 | 3 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.61e-04 | 183 | 34 | 3 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 184 | 34 | 3 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 184 | 34 | 3 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 3.73e-04 | 185 | 34 | 3 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 186 | 34 | 3 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.79e-04 | 186 | 34 | 3 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 186 | 34 | 3 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 186 | 34 | 3 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 186 | 34 | 3 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-04 | 186 | 34 | 3 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 186 | 34 | 3 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 3.91e-04 | 188 | 34 | 3 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 3.91e-04 | 188 | 34 | 3 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.91e-04 | 188 | 34 | 3 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.91e-04 | 188 | 34 | 3 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.97e-04 | 189 | 34 | 3 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.97e-04 | 189 | 34 | 3 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.97e-04 | 189 | 34 | 3 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-04 | 189 | 34 | 3 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-04 | 189 | 34 | 3 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.97e-04 | 189 | 34 | 3 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.03e-04 | 190 | 34 | 3 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.03e-04 | 190 | 34 | 3 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 4.03e-04 | 190 | 34 | 3 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.03e-04 | 190 | 34 | 3 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.03e-04 | 190 | 34 | 3 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.09e-04 | 191 | 34 | 3 | f229abf69a1217194f74b0502486907e07dba989 | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 9.95e-06 | 195 | 34 | 5 | 1514_DN | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.07e-05 | 198 | 34 | 5 | 2118_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 1.07e-05 | 198 | 34 | 5 | 6226_UP | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; PC3; HT_HG-U133A | 1.10e-05 | 199 | 34 | 5 | 4188_UP | |
| Drug | Bisoprolol fumarate; Down 200; 9uM; MCF7; HT_HG-U133A | 1.10e-05 | 199 | 34 | 5 | 2642_DN | |
| Drug | GTX1 | 4.52e-05 | 7 | 34 | 2 | CID003034749 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 1.65e-04 | 186 | 34 | 4 | 4463_UP | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.76e-04 | 189 | 34 | 4 | 2790_DN | |
| Drug | Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 191 | 34 | 4 | 5997_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A | 1.90e-04 | 193 | 34 | 4 | 4488_DN | |
| Drug | Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.94e-04 | 194 | 34 | 4 | 2863_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 3941_DN | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 2791_DN | |
| Drug | Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 2796_UP | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 5536_UP | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 2844_DN | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 5680_DN | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 4469_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 4108_DN | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 6003_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 2315_DN | |
| Drug | haloperidol; Up 200; 10uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 4468_UP | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 3899_DN | |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 6686_DN | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 6219_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 2768_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 6018_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; HL60; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 2488_UP | |
| Drug | Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 4506_DN | |
| Drug | Imidurea [39236-46-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 5481_DN | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 3443_DN | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 6053_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 6023_DN | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 5446_UP | |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; HL60; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 2479_UP | |
| Drug | arachidonyl trifluoromethyl ketone; Down 200; 10uM; MCF7; HG-U133A | 2.10e-04 | 198 | 34 | 4 | 594_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 4717_UP | |
| Drug | WY-14643; Up 200; 100uM; SKMEL5; HG-U133A | 2.10e-04 | 198 | 34 | 4 | 495_UP | |
| Drug | Methyldopa (L,-) [555-30-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 5272_DN | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 6275_UP | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 4967_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 4592_DN | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; MCF7; HT_HG-U133A_EA | 2.10e-04 | 198 | 34 | 4 | 881_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 7514_DN | |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 5420_DN | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 4808_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 3266_DN | |
| Drug | Tropine [120-29-6]; Up 200; 28.4uM; MCF7; HT_HG-U133A | 2.18e-04 | 200 | 34 | 4 | 6264_UP | |
| Drug | 2-azido-ATP | 2.90e-04 | 17 | 34 | 2 | CID000123645 | |
| Drug | DB-G | 3.26e-04 | 18 | 34 | 2 | CID000444845 | |
| Drug | SR 49059 | 3.64e-04 | 19 | 34 | 2 | CID000060943 | |
| Disease | body weight | 7.31e-05 | 1261 | 34 | 8 | EFO_0004338 | |
| Disease | Neurodevelopmental Disorders | 1.69e-04 | 93 | 34 | 3 | C1535926 | |
| Disease | amyloid-beta measurement | 7.18e-04 | 355 | 34 | 4 | EFO_0005194 | |
| Disease | hoarding disorder | 7.92e-04 | 36 | 34 | 2 | EFO_0803361 | |
| Disease | diet measurement | 1.14e-03 | 1049 | 34 | 6 | EFO_0008111 | |
| Disease | inflammatory bowel disease | 1.71e-03 | 449 | 34 | 4 | EFO_0003767 | |
| Disease | schizophrenia, sex interaction measurement | 2.19e-03 | 60 | 34 | 2 | EFO_0008343, MONDO_0005090 | |
| Disease | Hallux valgus | 2.19e-03 | 60 | 34 | 2 | HP_0001822 | |
| Disease | C-reactive protein measurement | 2.32e-03 | 1206 | 34 | 6 | EFO_0004458 | |
| Disease | susceptibility to vaginal yeast infection measurement | 2.56e-03 | 65 | 34 | 2 | EFO_0008412 | |
| Disease | susceptibility to chronic sinus infection measurement | 2.80e-03 | 68 | 34 | 2 | EFO_0008419 | |
| Disease | serum IgG glycosylation measurement | 2.97e-03 | 523 | 34 | 4 | EFO_0005193 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HAEKGQSDKMNTDDL | 41 | Q86TY3 | |
| TGKQHMFNEKEDSCN | 981 | Q8IZP9 | |
| KNQKMEKDSDGCHLK | 276 | Q3SXY8 | |
| DQLKHSLMKAEDDCK | 211 | Q9H257 | |
| KELQDSQDKCHKMEQ | 456 | O14578 | |
| EADSSDKEMKHGQKS | 206 | Q9C0F0 | |
| LKKMEDHGKNSCEEI | 316 | Q9ULJ1 | |
| NTFEGHKSKNKEDCD | 701 | Q6P0N0 | |
| KDTCDEFRSQMKNGK | 771 | Q9NQ38 | |
| QKGEAKCHKSDTGMS | 596 | Q4FZB7 | |
| NKDEGDVCNHEKKTA | 76 | Q9BPX6 | |
| KDSSQEGCKMENHLF | 876 | Q92953 | |
| NSELKKSLDCMHKDQ | 2671 | P49454 | |
| KSLDCMHKDQVEKEG | 2676 | P49454 | |
| DEMSENKDNCVKKHS | 571 | Q0VDD8 | |
| KTVHDECMKNSLKNE | 161 | P52429 | |
| NCDGSRDDKDKMSSK | 861 | Q14147 | |
| NKGDNSSMDDLHKKD | 496 | O75473 | |
| SEMKEGKACKQHVSQ | 551 | Q92834 | |
| QGQKKEMSCTAHGEK | 801 | O60469 | |
| TKEMEKQNTDKCHVS | 1306 | Q5T5P2 | |
| FDECHKAKNAGSTKM | 386 | Q9Y2G9 | |
| KEDDMNHCVKTFQEK | 31 | Q8WW14 | |
| ESSQTCHSEQGDKKM | 601 | P46063 | |
| CHSEQGDKKMEEKNS | 606 | P46063 | |
| SQSKTMGHQDKKDLC | 246 | A6NDS4 | |
| ANHKKSMLDKGESSC | 41 | Q9C035 | |
| TTKECDSDDNMGAKN | 1021 | Q9Y4E5 | |
| HLCDDSQKQEKEMNG | 66 | Q6ZNA4 | |
| QADVDTCRMKGKHKD | 101 | Q9H2E6 | |
| CQNMKEKFNKEDTDS | 366 | P37288 | |
| QSEDLKRDCGKKMSH | 6 | Q6ZNC4 | |
| HKNCGEMSEIEAKVK | 286 | Q9Y4G6 | |
| EKDGDSKHQKEICSM | 711 | Q502W6 | |
| VCEGDHKTMAKAIKD | 546 | Q9H4A3 | |
| ENCAMKGKHKDECHN | 106 | Q8NFY4 | |
| KSHGVMSKACTNDDQ | 476 | Q8NA31 |